Addex Starts Phase IIb ADX10059, Proton Pump Inhibitor Combination … – MarketWatch
|
Addex Starts Phase IIb ADX10059, Proton Pump Inhibitor Combination …
MarketWatch - Indeed, ADX10059 has been shown by Addex to reduce reflux and reduce esophageal acid exposure in two separate clinical trials. Research has also shown that … |
Finding, and Treating, Esophageal Cancer – New York Times
|
Finding, and Treating, Esophageal Cancer
New York Times, United States - Now that the role of acid reflux is well known in cancer risk and unpleasant conditions like chronic cough and hoarseness, drug companies market several … |
